Home/Rarecells/Prof Patrizia Paterlini-Bréchot, MD, PhD
PP

Prof Patrizia Paterlini-Bréchot, MD, PhD

President, CEO & Founder

Rarecells

Therapeutic Areas

Rarecells Pipeline

DrugIndicationPhase
ISET® CTC TestEarly Cancer Detection & Recurrence MonitoringCommercial
CTC-DNA + ctDNA AssayEarly Cancer Detection (e.g., Lung Cancer)Clinical Studies